美国食品药品监督管理局（FDA）批准艾伯维公司（AbbVie）的口服泛基因型直接抗病毒药物Mavyret（glecaprevir/pibrentasvir）扩大适应症，该药物成为 ...

HIV治疗耐药性是永久和不可逆的，这可能危及患者群体未来的治疗选择。在22%至63%的HIV感染者中发现了M184V/I耐药性，这些患者对各种HIV亚型的核苷逆转录酶抑制剂已有耐药性。

"No change to report at (Iran's nuclear facilities) Esfahan and Fordow," the IAEA added. In its statement published on Monday ...

近日，艾伯维宣布美国食品药品监督管理局（FDA）已批准其口服泛基因型直接抗病毒（DAA）药物Mavyret（glecaprevir/pibrentasvir）的扩大适应症，使其成为首个且唯一获批用于治疗成人及3岁及以上儿童（无肝硬化或代偿期肝硬化）急 ...

VIENNA, June 17 (Xinhua) -- There has been no additional damage at Iran's Natanz Fuel Enrichment Plant site since Friday's attack, and the radioactivity outside the Natanz site has remained unchanged ...

今日，Juvena Therapeutics宣布与礼来（Eli Lilly and ...

UNITED NATIONS, June 13 (Xinhua) -- International Atomic Energy Agency (IAEA) Director General Rafael Grossi on Friday called for maximum restraint after Israeli attacks on Iran, including on nuclear ...